Position in GLMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$48,289
+$42,712 QoQ
Shares Held
86,851
+663.1% QoQ
Ownership
1.05%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 13 holders
Holding Since
Mar 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLMD Over Time
Shares Held
Position Value (USD)
Derivatives in GLMD
reported options exposure · as of Sep 30, 2023CallValue
$26
CallShares
42
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,678,386 across 436 Biotechnology names. GLMD ranks #385 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in GLMD
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,289 | 86,851 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,577 | 11,382 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $28,670 | 38,177 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $69,678 | 50,492 | Shares | Defined | 2025-11-14 | |
| 2023-12-31 | $5,119 | 11,251 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $26 | 42 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $25,083 | 40,458 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $17,440 | 40,844 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $5,793 | 18,628 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $38,756 | 59,625 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $20,014 | 12,588 | Shares | Defined | 2022-05-16 | |
| 2021-09-30 | $78,438 | 28,114 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $119,584 | 39,337 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $41,344 | 13,600 | Call | Defined | 2021-08-16 | |
| 2021-03-31 | $50,764 | 14,800 | Call | Defined | 2021-05-21 | |
| No filing history on record for this holder in this stock. | ||||||